Covid-19: AstraZeneca vaccine prevents 79% of symptomatic disease and 100% of severe disease, US study finds

COVID-19 pandemic severely impacts mental health of young people
22 March 2021
Indian firm to make 200 mn doses of Russia’s Sputnik V
22 March 2021

Covid-19: AstraZeneca vaccine prevents 79% of symptomatic disease and 100% of severe disease, US study finds

Interim analysis of a phase III trial has found that the vaccine produced by Oxford University and AstraZeneca was 79% effective at preventing symptomatic covid-19 and 100% effective at preventing…

Comments are closed.